HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan Jin Selected Research

Tamoxifen

4/2010Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients.
7/2009Evaluating the role of serotonin in hot flashes after breast cancer using acute tryptophan depletion.
6/2009Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy.
12/2008Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy.
7/2006Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment.
3/2005The effects of tamoxifen and its metabolites on platelet function and release of reactive oxygen intermediates.
1/2005CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan Jin Research Topics

Disease

159Neoplasms (Cancer)
04/2024 - 07/2003
47Inflammation (Inflammations)
04/2024 - 07/2010
29Infections
01/2024 - 10/2003
29Lung Neoplasms (Lung Cancer)
08/2023 - 07/2003
28Wounds and Injuries (Trauma)
04/2024 - 12/2003
27Osteoporosis
04/2024 - 01/2008
19Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 11/2011
17Adenocarcinoma
01/2023 - 09/2009
16Pain (Aches)
02/2024 - 08/2007
16Adenocarcinoma of Lung
11/2023 - 03/2012
15Neoplasm Metastasis (Metastasis)
12/2024 - 07/2003
15Stomach Neoplasms (Stomach Cancer)
10/2023 - 02/2009
14Colitis
03/2023 - 10/2013
13Hypoxia (Hypoxemia)
11/2023 - 09/2012
13Carcinogenesis
01/2022 - 10/2003
13Breast Neoplasms (Breast Cancer)
02/2021 - 01/2005
11Obesity
04/2024 - 08/2013
11COVID-19
07/2023 - 01/2021
10Pancreatic Neoplasms (Pancreatic Cancer)
05/2021 - 07/2013
9Neuroblastoma
12/2024 - 03/2017
9Hepatocellular Carcinoma (Hepatoma)
01/2024 - 01/2012
9Type 2 Diabetes Mellitus (MODY)
07/2023 - 01/2011
9Insulin Resistance
01/2023 - 08/2013
9Periodontitis
11/2022 - 01/2013
8Myocardial Infarction
12/2020 - 03/2002
7Hypersensitivity (Allergy)
02/2024 - 08/2007
7Hyperalgesia
02/2023 - 08/2007
7Atrial Fibrillation
10/2022 - 07/2015
7Coronary Artery Disease (Coronary Atherosclerosis)
02/2017 - 01/2012
6Heart Failure
05/2024 - 10/2003
6Fibrosis (Cirrhosis)
03/2024 - 03/2011
6Alzheimer Disease (Alzheimer's Disease)
02/2024 - 12/2016
6Asthma (Bronchial Asthma)
11/2023 - 01/2015
6Lymphatic Metastasis
07/2021 - 08/2010
6Leukemia
01/2021 - 09/2003
6Carcinoma (Carcinomatosis)
09/2019 - 12/2003
6Ovarian Neoplasms (Ovarian Cancer)
10/2018 - 01/2013
6Congenital Preauricular Fistulae
10/2018 - 10/2016
5Experimental Arthritis
01/2024 - 01/2019
5Rheumatoid Arthritis
01/2024 - 01/2019
5Hypertension (High Blood Pressure)
12/2023 - 03/2015
5Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2023 - 10/2009
5Chronic Obstructive Pulmonary Disease (COPD)
11/2023 - 05/2011
5Neuroinflammatory Diseases
08/2023 - 01/2023
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2023 - 09/2013
5Mitochondrial Diseases (Mitochondrial Disease)
07/2023 - 01/2017
5Maternal Obesity
03/2023 - 08/2013
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2022 - 02/2010
5Cicatrix (Scar)
10/2022 - 08/2012
5Autoimmune Diseases (Autoimmune Disease)
10/2021 - 03/2009

Drug/Important Bio-Agent (IBA)

47Proteins (Proteins, Gene)FDA Link
01/2024 - 07/2003
29Biomarkers (Surrogate Marker)IBA
04/2024 - 08/2011
28MicroRNAs (MicroRNA)IBA
01/2022 - 01/2012
20DNA (Deoxyribonucleic Acid)IBA
12/2023 - 12/2003
20Messenger RNA (mRNA)IBA
11/2023 - 02/2008
18Therapeutic UsesIBA
01/2024 - 04/2005
15Glucose (Dextrose)FDA LinkGeneric
11/2022 - 01/2011
15Telomerase (Telomerase Reverse Transcriptase)IBA
04/2022 - 08/2010
13RNA (Ribonucleic Acid)IBA
01/2024 - 09/2006
13Long Noncoding RNAIBA
10/2023 - 02/2016
12CytokinesIBA
03/2024 - 03/2009
12EnzymesIBA
12/2023 - 01/2005
11Insulin (Novolin)FDA Link
01/2023 - 01/2011
11Estrogens (Estrogen)FDA Link
01/2023 - 12/2012
11AntigensIBA
10/2021 - 12/2003
10Anti-Bacterial Agents (Antibiotics)IBA
12/2023 - 04/2005
10LipidsIBA
05/2023 - 05/2013
8Protein Isoforms (Isoforms)IBA
11/2023 - 04/2016
7Cisplatin (Platino)FDA LinkGeneric
01/2024 - 04/2015
7Dextran SulfateIBA
09/2023 - 10/2013
7Interleukin-17 (Interleukin 17)IBA
11/2022 - 12/2012
7ErbB Receptors (EGF Receptor)IBA
09/2015 - 01/2013
7TamoxifenFDA LinkGeneric
04/2010 - 01/2005
6HydrogelsIBA
04/2024 - 09/2009
6Peptides (Polypeptides)IBA
01/2024 - 08/2020
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2023 - 01/2010
6Circular RNAIBA
11/2023 - 12/2019
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2023 - 04/2011
6CalciumIBA
02/2023 - 01/2017
6Transcription Factors (Transcription Factor)IBA
01/2023 - 08/2013
6Tyrosine Kinase InhibitorsIBA
10/2022 - 02/2013
6Cadherins (E-Cadherin)IBA
11/2020 - 01/2013
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2016 - 01/2012
5Nerve Growth Factor (NGF)IBA
01/2024 - 02/2007
5Carbapenems (Carbapenem Antibiotics)IBA
01/2024 - 03/2017
5VaccinesIBA
12/2023 - 05/2008
5Reactive Oxygen Species (Oxygen Radicals)IBA
11/2023 - 03/2005
5VimentinIBA
10/2023 - 01/2013
5SmokeIBA
08/2023 - 07/2010
5Placental Lactogen (Human Placental Lactogen)IBA
03/2023 - 08/2013
5Analgesics (Analgesic Drugs)IBA
12/2022 - 08/2011
5InterferonsIBA
01/2022 - 01/2016

Therapy/Procedure

80Therapeutics
05/2024 - 10/2003
18Immunotherapy
04/2024 - 09/2015
16Drug Therapy (Chemotherapy)
11/2022 - 12/2008
10Transplantation
06/2019 - 12/2005
7Ovariectomy (Oophorectomy)
01/2016 - 01/2012
6Length of Stay
08/2022 - 08/2002
5Gastrectomy
04/2024 - 01/2013
5Radiotherapy
11/2022 - 05/2017